Abstract
S194 228 Clinical description of acute promyelocytic leukemia (APL) patients receiving all-trans retinoic acid (ATRA) who develop pseudotumor cerebri: Incidence, diagnosis, outcomes, and recommendations for management Catherine C. Coombs, Lisa M. DeAngelis, James H. Feusner, Martin S. Tallman Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center; Department of Neurology, Memorial Sloan Kettering Cancer Center; Department of Hematology/Oncology, Children’s Hospital & Research Center
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
